Alcohols-buliding-blocks

Duarte, Larissa Marinho; Ferreira, Sila Mary Rodrigues; Almeida, Claudia Choma Bettega; Duran, Ana Clara da Fonseca Leitao; Grilo, Mariana Fagundes; Macedo, Mariana de Souza; Franceschini, Sylvia do Carmo Castro; Crispim, Sandra Patricia published an article in 2022, the title of the article was Dietary exposure to low-calorie sweeteners in a sample of Brazilian pregnant women.Formula: C12H24O11 And the article contains the following content:

The dietary exposure to low-calorie sweeteners (LCS) was estimated in a sample of pregnant Brazilian women. Consumption data were obtained with a 24-h Dietary Recall interview. Because of the uncertainty in assessing foods with LCS, they were classified into three scenarios to ensure inclusion of the 15 LCS allowed for use in Brazil: ranging from a less to a more conservative scenario. The concentration of LCS was estimated using the amount declared on the label or the maximum permitted levels and anal. determination data for table-top sweeteners. The frequency of consumption was higher for acesulfame-K, aspartame, and cyclamate. The food groups contributing the most to the consumption of LCS were non-alc. beverages, table-top sweeteners, confectionary and desserts. The level of dietary exposure to LCS was within the safety limit. However, continued efforts to monitor their dietary exposure are necessary given the limitations highlighted in this study. The experimental process involved the reaction of SweetPearlR P300 DC Maltitol(cas: 585-88-6).Formula: C12H24O11

The Article related to acesulfamek aspartame cyclamate low calorie sweetener pregnancy, exposure assessment, acesulfame-k, aspartame, cyclamate, processed foods, sweeteners, Animal Nutrition: Carbohydrates, Fiber, and Energy and other aspects.Formula: C12H24O11

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Gonzalez-Rodriguez, Maria; Redruello-Requejo, Marina; Samaniego-Vaesken, Maria de Lourdes; Montero-Bravo, Ana; Puga, Ana M.; Partearroyo, Teresa; Varela-Moreiras, Gregorio published an article in 2021, the title of the article was Low- and No-Calorie Sweetener (LNCS) Presence and Consumption among the Portuguese Adult Population.Electric Literature of 585-88-6 And the article contains the following content:

The use of low and no-calorie sweeteners (LNCS) in food and beverages has become increasingly common in the development and reformulation of products to reduce energy derived from added sugars. Our aim was to identify the presence and consumption of LNCS through food and beverages according to consumption patterns in a representative sample (n = 256) of the Portuguese adult population. The study had a descriptive cross-sectional observational design and was based on the application of a Food Frequency Questionnaire. Overall, it was found that 4.1% of the foods and 16.7% of the beverages consumed by the Portuguese adult population contained LNCS. Food groups mostly contributing to LNCS consumption were non-alc. beverages such as soft drinks and juices (34.2%); milk and dairy products (16.5%); appetizers such as chips (8.6%); sugars and sweets such as chocolates, candies, or chewing gums (6.1%); meat and derivative products (2.2%); cereals and derivatives (1.2%) and canned fruits (1.2%). Main LNCS consumed were acesulfame-K, sucralose, and aspartame, single or combined, although their prevalence of use differs greatly among foods, beverages, or tabletop sweeteners. In conclusion, LNCS were found across a wide variety of products available in the Portuguese market and their prevalence of inclusion in the diet of the population evidences the need to develop more studies on the evolution of LNCS intake and its impact on the full dietary model and health. Consequently, these food additives should be included in food composition databases and, periodically, updated to reflect the recurrent reformulation strategies adopted by the food industry in its efforts to reduce the energy contribution of added sugars. The experimental process involved the reaction of SweetPearlR P300 DC Maltitol(cas: 585-88-6).Electric Literature of 585-88-6

The Article related to low number calorie sweetener portugal, portuguese population, additives, artificial sweeteners, food groups, low- and no-calorie sweeteners, processed foods, Animal Nutrition: Carbohydrates, Fiber, and Energy and other aspects.Electric Literature of 585-88-6

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On June 5, 2022, Marshall, Tatianna; Marangoni, Alejandro G.; Laredo, Thamara; Al-Abdul-Wahid, M. Sameer; Pensini, Erica published an article.Computed Properties of 585-88-6 The title of the article was Mechanisms of solvent separation using sugars and sugar alcohols. And the article contained the following:

This study uses sugars (dextrose, sucrose, ribose, fructose and mannose) and sugar alcs. (maltitol, erythritol, sorbitol, xylitol) to sep. water from THF (THF) and acetonitrile (AN). Bottle tests and NMR (NMR) show that above 0.25 M all sugars and sugar alcs. effectively sep. water from either THF or AN. At 0.5 M concentrations, maltitol and sucrose yield a non-negligible interfacial tension between AN and water, while the interfacial tension is negligible with all other compounds This indicates that while all compounds have similar separation effectiveness above a benchmark concentration, maltitol and sucrose (which are dimers) have a stronger effect on water structure compared to the other compounds tested (which are monomers). Attenuated Total Reflectance – Fourier Transform IR spectroscopy (ATR-FTIR) was used to explain solvent separation, based on the effect of sugars on hydrogen bonding (H-bonding) and on the nitrile band. The H-bonding peak was deconvolved into peaks representative of different water clusters, comprised of water mols. donating and accepting a different number of H-bonds. Principal component anal. (PCA) shows that single H-bond donors (SD) (at approx. 3200 cm-1) and double H-bond donor (DD) (at approx. 3400 cm-1) are most affected by maltitol and sucrose. All sugars tested induce a blue shift of the H-bonding of absorbance peaks for DD and SD, in either water or in mixtures of water-AN and water-THF. This indicates that they strengthen H-bonding in these clusters. The effect of all sugars is comparable when concentrations are expressed as OH equivalent Sugars increase the ratio between the amplitude A of SD relative to DD, and SD are most effective at structuring water. The difference between the ratio A(SD)/A(DD) after and before sugar addition is lowest in water (≈0.9), followed by THF-water mixtures (≈1.1) and AN-water mixtures (≈1.2). This indicates that solvents enhance the effect of sugars on H bonding. This is likely because sugars are not soluble in either THF or AN, which therefore excludes them and promotes their interactions with water. In turn, water-sugar H-bonding weakens interactions between AN-water or THF-water, leading to solvent separation The anal. of the nitrile band shows that sugars and sugar alcs. increase the relative amount of free nitrile, which is correlated to weaker interactions between AN and water. Maltitol and sucrose display approx. two times the relative amount of free nitrile compared to dextrose and erythritol. Our study confirms that sugars and sugar alcs. weaken solvent-water interactions, and reveals that they sep. solvents by increasing the proportion of SD relative to DD. The experimental process involved the reaction of SweetPearlR P300 DC Maltitol(cas: 585-88-6).Computed Properties of 585-88-6

The Article related to mechanism solvent separation sugar alc, Unit Operations and Processes: Separation Processes and other aspects.Computed Properties of 585-88-6

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On March 14, 2019, Ashcraft, Luke; Boezio, Alessandro; Butler, John; Chandra, Aroop; Chuang, Chihyuan; Collibee, Scott E.; Debenedetto, Mikkel; Dimassa, Vincent; Graceffa, Russell; Malinowski, Justin; Moebius, David; Morgan, Bradley P.; Payette, Joshua; Romero, Antonio; St. Jean, David, Jr.; Vargas, Richard; Yeoman, John; Zhang, Hanmo published a patent.Application of 306281-86-7 The title of the patent was Bisamides as cardiac sarcomere modulators and their preparation. And the patent contained the following:

The invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof. Compounds of formula I wherein Q is (un)substituted aryl, (un)substituted sulfonylpyrrolidinyl, (un)substituted 5- to 6-membered heteroaryl, etc.; X1 is N and CR2; X2, X3, X4 and X5 are independently N and CR3, provided at 0, 1 or 2 of X1 – X5 are N and the remaining are CR2 and CR3; R1a is H, C1-6 alkyl and halo; R1 is H, C1-6 alkyl, C1-6 alkenyl, C2-6 alkynyl, etc.; R2 is H, halo, C1-6 alkyl, C1-6 haloalkyl, etc.; R1R2 can be taken together to form (CH2)1-3, OCH2, CH2OCH2, etc.; R3 is H, halo, C1-6 alkyl, SF5, etc.; R13a is H and C1-6 alkyl; R13 and R14 are independently C1-6 alkyl, C3-7 cycloalkyl, and C3-7 cycloalkyl-C1-6 alkyl; R13R14 can be taken together to form (un)fused (un)saturated 4- to 7-membered heterocyclyl; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by amidation of (R)-1-((S)-1-((3-cyanoazetidin-1-yl)sulfonyl)piperidine-3-carbonyl)pyrrolidine-2-carboxylic acid with benzylamine. The invention compounds were evaluated for their cardiac sarcomere modulatory activity (some data given). The experimental process involved the reaction of (R)-2-Amino-2-(4-(trifluoromethyl)phenyl)ethanol(cas: 306281-86-7).Application of 306281-86-7

The Article related to bisamide preparation sarcomere modulator, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Application of 306281-86-7

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On June 25, 2006, Yang, Dehong; Yang, Benyong; Li, Hui published an article.Category: alcohols-buliding-blocks The title of the article was Synthesis of 2-(methyl-2-pyridinylamino)ethanol. And the article contained the following:

The title compound [i.e., 2-[methyl(2-pyridinyl)amino]ethanol] is a key intermediate in the synthesis of rosiglitazone. A reaction of 2-chloropyridine with two equivalent 2-(methylamino)ethanol gave the target compound and 2-(methylamino)ethanol hydrochloride. To enhance the reaction yield, appropriately increasing reaction temperature and changing post-treatment can shorten reaction time to 7-8 h, simplify the operation and significantly improve the yield to 95%. The experimental process involved the reaction of 2-(Methylamino)ethan-1-ol hydrochloride(cas: 62640-03-3).Category: alcohols-buliding-blocks

The Article related to rosiglitazone methylpyridinylamino ethanol preparation, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Category: alcohols-buliding-blocks

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On February 15, 2012, McConnell, Ivan; Benchikh, Elouard; Fitzgerald, Peter; Lowry, Philip published a patent.HPLC of Formula: 78-26-2 The title of the patent was Preparation and use of immunogens for development of meprobamate immunoassay with carisoprodol crossreactivity. And the patent contained the following:

Carisoprodol is a centrally-acting prescription drug of known abuse. Upon ingestion it is rapidly metabolized to meprobamate, also a prescription drug with abuse potential. Current immunoassays are specific for carisoprodol and therefore have a short window of detection and, furthermore, are ineffective at detecting meprobamate. The current invention, underpinned by an antibody specific for meprobamate, overcomes these deficiencies. The experimental process involved the reaction of 2-Methyl-2-propylpropane-1,3-diol(cas: 78-26-2).HPLC of Formula: 78-26-2

The Article related to forensic meprobamate immunoassay carisoprodol test kit, Toxicology: Forensic Chemistry (Including Analysis) and other aspects.HPLC of Formula: 78-26-2

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On February 17, 2005, Vanotti, Ermes; D’Alessio, Roberto; Tibolla, Marcellino; Varasi, Mario; Montagnoli, Alessia; Santocanale, Corrado; Martina, Katia; Menichincheri, Maria published a patent.COA of Formula: C7H8FNO The title of the patent was Preparation of pyridylpyrrole derivatives active as kinase inhibitors. And the patent contained the following:

Pyridylpyrrole derivatives of formula I [R1 = H, amino, etc.; R2, R’2 = H, halo, etc.; further detail on R1 and R’2 is given; R3, R’3, R4, R’4 = H, alkyl, etc.; R5 = H, halo, etc.] and pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer. Thus, 2-(2-cyclopentylaminopyridin-4-yl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one was prepared from 2-(2-chloropyridin-4-yl)-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one and cyclopentylamine. Compounds of this invention in vitro showed IC50 values of 2 nM to 20 nM against Cdc7 kinase. The experimental process involved the reaction of 1-(3-Fluoropyridin-4-yl)ethanol(cas: 87674-15-5).COA of Formula: C7H8FNO

The Article related to pyridylpyrrole derivative preparation kinase inhibitor, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.COA of Formula: C7H8FNO

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On June 30, 2020, Honorato de Castro, Ana Cristina; Alves, Livia Maria; Siquieroli, Ana Carolina Silva; Madurro, Joao Marcos; Brito-Madurro, Ana Graci published an article.Formula: C8H8O3 The title of the article was Label-free electrochemical immunosensor for detection of oncomarker CA125 in serum. And the article contained the following:

This paper reports the construction of a new electrochem. immunosensor for detection of oncomarker CA125 for diagnosis and monitoring of ovarian cancer. The platform was developed using screen-printed carbon electrodes modified with poly(3-hydroxyphenylacetic acid) and anti-CA125 as probe for evaluate the biomol. interactions (anti-CA125:CA125) onto the solid surface. Current response of the system has a linear relationship of anti-CA125 concentration in the range of 5 to 80 U mL-1 with a limit of detection of 1.45 U mL-1, discriminating between neg. and pos. serum. The immunosensor was successfully applied to determination of CA-125 in real biol. samples using differential pulse voltammetry (DPV), surface plasmon resonance (SPR) and at. force microscopy (AFM). The results showed the developed immunosensor is versatile, easily integrated to the point of care applications, being an interesting platform to ovarian cancer diagnose in complex samples. The experimental process involved the reaction of 3-Hydroxyphenylacetic acid(cas: 621-37-4).Formula: C8H8O3

The Article related to ovarian cancer serum oncomarker electrochem immunosensor, Biochemical Methods: Cytochemical and Histochemical and other aspects.Formula: C8H8O3

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On March 3, 2011, Gradl, Stefan; Laird, Ellen; Moreno, David; Ren, Li; Wenglowsky, Steven Mark published a patent.Name: (6-(Trifluoromethyl)pyridin-3-yl)methanol The title of the patent was Preparation of 1H-pyrazolo[3,4-b]pyridine compounds useful for inhibiting Raf kinase. And the patent contained the following:

Title compounds I [R1 = H, halo, CN, etc.; R2 and R3 independently = H, halo, alkyl or alkoxy; R4 and R5 independently = H, halo or alkyl; R6 = (un)substituted Ph, 5- to 6-membered heteroaryl, 9- to 10-membered bicyclic heterocyclyl or heteroaryl; R7 = H or methyl], and their stereoisomers, tautomers or pharmaceutically acceptable salts, are prepared Thus, e.g., II was prepared by cyclization of 5-methoxy-1H-pyrazol-3-amine with sodium nitromalonaldehyde monohydrate followed by reduction and acylation with 3-(benzyloxy)benzoic acid. Compounds of the invention were evaluated for their inhibitory activity of human recombinant B-Raf protein and were found to have an IC50 value of < 1 μM. Methods of using such compounds for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders including cancer in mammalian cells, or associated pathol. conditions are disclosed. The experimental process involved the reaction of (6-(Trifluoromethyl)pyridin-3-yl)methanol(cas: 386704-04-7).Name: (6-(Trifluoromethyl)pyridin-3-yl)methanol

The Article related to pyrazolopyridine preparation raf kinase inhibitor cancer, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Name: (6-(Trifluoromethyl)pyridin-3-yl)methanol

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

On September 20, 2007, Imogai, Hassan Julien; Cid-Nunez, Jose Maria; Andres-Gil, Jose Ignacio; Trabanco-Suarez, Andres Avelino; Oyarzabal Santamarina, Julen; Dautzenberg, Frank Matthias; MacDonald, Gregor James; Pullan, Shirley Elizabeth; Luetjens, Robert Johannes; Duvey, Guillaume Albert Jacques; Nhem, Vanthea; Finn, Terry Patrick; Melikyan, Gagik published a patent.Safety of (6-(Trifluoromethyl)pyridin-3-yl)methanol The title of the patent was 1,4-Disubstituted 3-cyanopyridone derivatives and their use as positive allosteric modulators of mGlu2-receptors and their preparation. And the patent contained the following:

The invention relates to compounds, in particular pyridinone derivatives according to formula I wherein all radicals are defined in the application and claims. Compounds of formula I wherein V1 is a covalent bond and bivalent (un)saturated (un)branched C1-6 hydrocarbon radical; M1 is H, C3-7 cycloalkyl, aryl, alkylcarbonyl, alkyloxy, aryloxy, arylcarbonyl, etc.; L is a covalent bond, O, OCH2, OCH2CH2, OCH2CH2O, OCH2CH2OCH2, S, NH and derivatives, etc.; R2 and R3 are independently H, halo and alkyl; A is (un)substituted Ph, (un)substituted piperazinyl, (un)substituted piperidinyl, (un)substituted thienyl, (un)substituted furanyl, etc.; R4 is halo, CN, OH, oxo, formyl, ethanoyl, carboxyl, NO2, etc.; n is 0, 1, 2, and 3; and their pharmaceutically acceptable acid and addition base salts, stereochem. isomeric forms, N-oxides, and quaternary ammonium salts thereof, are claimed. The compounds according to the invention are pos. allosteric modulators of metabotropic receptors – sub-type 2 (“”mGluR2″”) which are useful for the treatment or prevention of neurol. and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved. Example compound II was prepared by a general procedure (procedure given). All the invention compounds were evaluated for their mGlu-2 receptor modulatory activity. From the assay, it was determined that compound II exhibited a pEC50 value of 6.2. The experimental process involved the reaction of (6-(Trifluoromethyl)pyridin-3-yl)methanol(cas: 386704-04-7).Safety of (6-(Trifluoromethyl)pyridin-3-yl)methanol

The Article related to disubstituted cyanopyridone preparation mglur2 modulator, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Safety of (6-(Trifluoromethyl)pyridin-3-yl)methanol

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts